Tune In | M&A In Pharma 

Our Partner, Clarence Anthony, speaks with Sandeep K. Rathod, Global General Counsel & Head of Compliance at Piramal Pharma Limited, about his M&A experience in pharmaceuticals and healthcare, and what one can expect in the next couple of years in this space.
The discussion revolves around identifying legal risks in pharma M&A deals and the structuring of in-house and external counsel teams to complement each other’s expertise when getting the deal done. They talk about IP issues, and confidentiality and data privacy, in the context of M&A deals in the pharmaceutical sector.
Finally, they delve into the outlook for the pharma sector in the next two years and elaborate on some emerging trends such as an increased focus on medical devices, the possibility of PE exits, and potential IPOs.
To view more content from the latest issue of the Trilegal Quarterly Roundup, visit the link: trilegal.com/m...